Save your place

Sign in to WhoBought

Please try again later.

Mersana Therapeutics, Inc. (MRSN) institutional ownership

Market cap$145M SectorHealthcare
Funds holding · Q1 2026
49
reported MRSN position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
0 buyers · 49 sellers

Mersana Therapeutics, Inc. (MRSN) price and institutional activity

Dates

Q1 2026

$0 bought by 0 investors
$0 sold by 49 investors
Nextech Invest, Ltd.Bain Capital Life Sciences Investors, LLC +47 more
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

Mersana Therapeutics, Inc. (MRSN) institutional activity · 49

Investor Type Est. change Change Δ Own Date
Nextech Invest, Ltd. · Exited
Change −483K Δ Own −100.0% Date Q1 2026
Nextech Invest, Ltd. Exited· Q1 2026 −483K −100.0% Q1 2026
Bain Capital Life Sciences Investors, LLC · Exited
Change −347K Δ Own −100.0% Date Q1 2026
Bain Capital Life Sciences Investors, LLC Exited· Q1 2026 −347K −100.0% Q1 2026
Rock Springs Capital Management LP · Exited
Change −153K Δ Own −100.0% Date Q1 2026
Rock Springs Capital Management LP Exited· Q1 2026 −153K −100.0% Q1 2026
Knott David M Jr · Exited
Change −112K Δ Own −100.0% Date Q1 2026
Knott David M Jr Exited· Q1 2026 −112K −100.0% Q1 2026
Acadian Asset Management LLC · Exited
Change −111K Δ Own −100.0% Date Q1 2026
Acadian Asset Management LLC Exited· Q1 2026 −111K −100.0% Q1 2026
Affinity Asset Advisors, LLC · Exited
Change −100K Δ Own −100.0% Date Q1 2026
Affinity Asset Advisors, LLC Exited· Q1 2026 −100K −100.0% Q1 2026
BlackRock · Exited
Change −69K Δ Own −100.0% Date Q1 2026
BlackRock Exited· Q1 2026 −69K −100.0% Q1 2026
Bank of America Corp · Exited
Change −66K Δ Own −100.0% Date Q1 2026
Bank of America Corp Exited· Q1 2026 −66K −100.0% Q1 2026
Millennium Management LLC · Exited
Change −63K Δ Own −100.0% Date Q1 2026
Millennium Management LLC Exited· Q1 2026 −63K −100.0% Q1 2026
Groupe la Francaise · Exited
Change −61K Δ Own −100.0% Date Q1 2026
Groupe la Francaise Exited· Q1 2026 −61K −100.0% Q1 2026
Rangeley Capital, LLC · Exited
Change −57K Δ Own −100.0% Date Q1 2026
Rangeley Capital, LLC Exited· Q1 2026 −57K −100.0% Q1 2026
Gabelli Funds LLC · Exited
Change −47K Δ Own −100.0% Date Q1 2026
Gabelli Funds LLC Exited· Q1 2026 −47K −100.0% Q1 2026
Geode · Exited
Change −44K Δ Own −100.0% Date Q1 2026
Geode Exited· Q1 2026 −44K −100.0% Q1 2026
Credit Industriel Et Commercial · Exited
Change −41K Δ Own −100.0% Date Q1 2026
Credit Industriel Et Commercial Exited· Q1 2026 −41K −100.0% Q1 2026
AQR Capital Management LLC · Exited
Change −37K Δ Own −100.0% Date Q1 2026
AQR Capital Management LLC Exited· Q1 2026 −37K −100.0% Q1 2026
Data through Q1 2026 · filed May 27, 2026
15 of 49

Famous investor activity in Mersana Therapeutics, Inc. (MRSN)

Mersana Therapeutics, Inc. (MRSN) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Hack Andrew A. F. · Director 2 operations -347K
Owned 0 Trade date Jan 6, 2026 Filed date Jan 6, 2026
Hack Andrew A. F. Director 2 operations -347K 0 Jan 6, 2026 Jan 6, 2026
Hack Andrew A. F. · Director 11 operations -13K
Owned 0 Trade date Jan 6, 2026 Filed date Jan 6, 2026
Hack Andrew A. F. Director 11 operations -13K 0 Jan 6, 2026 Jan 6, 2026
Hege Kristen · Director Other Form 4 events -578
Owned 0 Trade date Jan 6, 2026 Filed date Jan 6, 2026
Hege Kristen Director Other Form 4 events -578 0 Jan 6, 2026 Jan 6, 2026
Hege Kristen · Director 17 operations -14K
Owned 0 Trade date Jan 6, 2026 Filed date Jan 6, 2026
Hege Kristen Director 17 operations -14K 0 Jan 6, 2026 Jan 6, 2026
Diaz Allene M. · Director Other Form 4 events -578
Owned 0 Trade date Jan 6, 2026 Filed date Jan 6, 2026
Diaz Allene M. Director Other Form 4 events -578 0 Jan 6, 2026 Jan 6, 2026
Diaz Allene M. · Director 6 operations -9K
Owned 0 Trade date Jan 6, 2026 Filed date Jan 6, 2026
Diaz Allene M. Director 6 operations -9K 0 Jan 6, 2026 Jan 6, 2026
Dere Willard H. · Director Other Form 4 events -2K
Owned 0 Trade date Jan 6, 2026 Filed date Jan 6, 2026
Dere Willard H. Director Other Form 4 events -2K 0 Jan 6, 2026 Jan 6, 2026
Dere Willard H. · Director 12 operations -12K
Owned 0 Trade date Jan 6, 2026 Filed date Jan 6, 2026
Dere Willard H. Director 12 operations -12K 0 Jan 6, 2026 Jan 6, 2026
Carvajal Alejandra · Officer Other Form 4 events -3K
Owned 0 Trade date Jan 6, 2026 Filed date Jan 6, 2026
Carvajal Alejandra Officer Other Form 4 events -3K 0 Jan 6, 2026 Jan 6, 2026
Carvajal Alejandra · Officer 12 operations -36K
Owned 0 Trade date Jan 6, 2026 Filed date Jan 6, 2026
Carvajal Alejandra Officer 12 operations -36K 0 Jan 6, 2026 Jan 6, 2026
Bala Mohan · Officer Other Form 4 events -3K
Owned 0 Trade date Jan 6, 2026 Filed date Jan 6, 2026
Bala Mohan Officer Other Form 4 events -3K 0 Jan 6, 2026 Jan 6, 2026
Bala Mohan · Officer 11 operations -37K
Owned 0 Trade date Jan 6, 2026 Filed date Jan 6, 2026
Bala Mohan Officer 11 operations -37K 0 Jan 6, 2026 Jan 6, 2026
Alleva Lawrence M. · Director 2 operations -662
Owned 0 Trade date Jan 6, 2026 Filed date Jan 6, 2026
Alleva Lawrence M. Director 2 operations -662 0 Jan 6, 2026 Jan 6, 2026
Alleva Lawrence M. · Director 22 operations -15K
Owned 0 Trade date Jan 6, 2026 Filed date Jan 6, 2026
Alleva Lawrence M. Director 22 operations -15K 0 Jan 6, 2026 Jan 6, 2026
Huber Martin H. Jr · Director, Officer Other Form 4 events -10K
Owned 0 Trade date Jan 6, 2026 Filed date Jan 6, 2026
Huber Martin H. Jr Director, Officer Other Form 4 events -10K 0 Jan 6, 2026 Jan 6, 2026
15 of 26
15 of 26 Sign in to continue to older insider transactions.

Mersana Therapeutics, Inc. (MRSN) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
The Vanguard Group 210K
% of shares outstanding 4.2% Filing date Jan 30, 2026
The Vanguard Group 210K 4.2% Jan 30, 2026
683 Capital Management, LLC 0
% of shares outstanding 0.0% Filing date May 15, 2026
683 Capital Management, LLC 0 0.0% May 15, 2026
Schonfeld Strategic Advisors LLC 0
% of shares outstanding 0.0% Filing date Feb 17, 2026
Schonfeld Strategic Advisors LLC 0 0.0% Feb 17, 2026
Nextech Crossover I Gp S.A. R.l. 0
% of shares outstanding 0.0% Filing date Jan 9, 2026
Nextech Crossover I Gp S.A. R.l. 0 0.0% Jan 9, 2026
4 of 4

Mersana Therapeutics, Inc. (MRSN) ownership FAQ

Who owns MRSN?

49 reporting institutions disclosed MRSN position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.